1. Assessing the true prevalence of endometriosis: A narrative review of literature data.
- Author
-
Harder, Carolin, Velho, Renata Voltolini, Brandes, Iris, Sehouli, Jalid, and Mechsner, Sylvia
- Subjects
- *
HEALTH insurance companies , *CHILDBEARING age , *HEALTH insurance , *ENDOMETRIOSIS , *QUALITY of life - Abstract
Endometriosis is a gynecologic condition often described as the "chameleon of gynecology" because of its elusive symptoms. The World Health Organization acknowledges its severe impact on quality of life due to pain, fatigue, depression, and infertility. There is limited literature on the prevalence of endometriosis, knowledge of which is essential for effective prevention, treatment strategies, and funding. We aim to structure and present the published data on endometriosis prevalence, synthesizing the discrepancy between health insurance and clinical data. PubMed, Cochrane CENTRAL, and LIVIVO were researched for peer‐reviewed articles published between January 2000 and July 2023 on women of reproductive age. Health insurance companies argue that few women (~1%) are affected by endometriosis. Interestingly, the prevalence of clinical data studies (6.8%), population‐based surveys/self‐reported studies (6.6%), and symptomatic patient data (21%) revealed a different picture. Based on the data gathered, a multi‐layered prevalence model has been proposed to illustrate the large discrepancy in the prevalence numbers, leading to the disease being underestimated and underfunded. This variability may be influenced by the heterogeneity in designs and the analyzed data, and clinical complexity. In summary, this narrative review reveals that the prevalence of endometriosis is higher than health insurance and other stakeholders might have previously assumed. Synopsis: Key findings lie in the synthesized review: when prevalence data on endometriosis are disaggregated, a clear picture emerges as to why the data differ greatly. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF